Spencer, Riley K. http://orcid.org/0000-0002-7047-5146
Jin, Joy Q.
Elhage, Kareem G.
Davis, Mitchell S.
Hakimi, Marwa
Gondo, George
Liao, Wilson
Bhutani, Tina
Article History
Received: 10 August 2023
Accepted: 15 September 2023
First Online: 5 October 2023
Declarations
:
: Joy Q Jin is supported in part by research grant funding from the National Psoriasis Foundation. Dr. Tina Bhutani is a principal investigator for trials sponsored by Abbvie, Castle, CorEvitas, Dermavant, Galderma, Mindera, and Pfizer. She has received research grant funding from Novartis and Regeneron. She has been an advisor for Abbvie, Arcutis, Boehringer-Ingelheim, Bristol Myers Squibb, Janssen, Leo, Lilly, Novartis, Pfizer, Sun, and UCB. Dr. Wilson Liao has received research grant funding from Abbvie, Amgen, Janssen, Leo, Novartis, Pfizer, Regeneron, and TRex Bio. George Gondo is an employee of the National Psoriasis Foundation. No conflicts of interest are applicable to this project. Riley Kyle Spencer has nothing to disclose. Kareem Giovanni Elhage has nothing to disclose. Mitchell Sparling Davis has nothing to disclose. Marwa Hakimi has nothing to disclose.
: This research project involving survey data has been conducted in compliance with the relevant ethical guidelines and principles including informed consent, confidentiality and privacy, risk assessment, and data protection and security. Institutional review board (IRB) approval for the 2020 NPF Annual Survey was obtained from Genetic Alliance and this study conformed with the Helsinki Declaration of 1964, as revised in 2013, concerning human rights.